- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 19th, 2005
Helmut Kaiser concluded that "the potentials are immense, and the risks too". Innovest says that companies that do not manage both the actual risks and the perceived ones could suffer public backlash and considerable brand impairment.
... some scientists argue that nanotechnology should not be treated in isolation. Mark Welland, head of the Nanoscience Centre at the University of Cambridge, says: "Ideas that a taskforce or new regulator are necessary are misplaced. If the US Food and Drug Administration is giving approval for a new drug, it would just need to look at the nanotechnology aspect in addition to what it always does."
|Related News Press|
Preparing for Nano
Durnham University's DEEPEN project comes to a close September 26th, 2012
Technical Seminar at ANFoS 2012 August 22nd, 2012
Nanotechnology shows we can innovate without economic growth April 12th, 2012
Thailand to host NanoThailand 2012 December 18th, 2011